Cite

HARVARD Citation

    Arnold, S. et al. (2022). Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors. Rheumatology. pp. 131-138. [Online]. 
  
Back to record